JBC Ideal method for primary cell transfection

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Umikawa, M.
Right arrow Articles by Takai, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Umikawa, M.
Right arrow Articles by Takai, Y.

J Biol Chem, Vol. 274, Issue 36, 25197-25200, September 3, 1999

COMMUNICATION
Association of Frabin with the Actin Cytoskeleton Is Essential for Microspike Formation through Activation of Cdc42 Small G Protein*

Masato UmikawaDagger §, Hiroshi Obaishi§parallel , Hiroyuki NakanishiDagger , Keiko Satoh-Horikawa, Kenichi Takahashi, Ikuko HottaDagger , Yoshiharu Matsuura**, and Yoshimi TakaiDagger Dagger Dagger

From the Dagger  Department of Molecular Biology and Biochemistry, Osaka University Medical School, Suita 565-0871, Japan, the  Takai Biotimer Project, ERATO, Japan Science and Technology Corporation, c/o JCR Pharmaceuticals Co. Ltd., 2-2-10 Murotani, Nishi-ku, Kobe 651-2241, Japan, and the ** Department of Virology II, National Institute of Infectious Disease, Tokyo 162-8640, Japan

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

We have recently isolated a novel actin filament-binding protein, named frabin. Frabin has one actin filament-binding domain (ABD), one Dbl homology domain (DHD), first pleckstrin homology domains (PHD) adjacent to DHD, one cysteine rich-domain (CRD), and second PHD from the N terminus to the C terminus in this order. Full-length frabin induces microspike formation and c-Jun N-terminal kinase (JNK) activation. We found here that the fragment of frabin containing DHD and first PHD stimulated guanine nucleotide exchange of Cdc42Hs small G protein, but not that of RhoA or Rac1 small G protein. However, this fragment of frabin did not induce microspike formation, and ABD was additionally necessary for microspike formation. Frabin having ABD was associated with the actin cytoskeleton, whereas frabin lacking ABD was diffusely distributed in the cytoplasm. In contrast, ABD was not necessary for JNK activation but CRD and second PHD were additionally necessary for this activation. These results indicate that the association of frabin with the actin cytoskeleton is essential for microspike formation but not for JNK activation and that different domains of frabin are involved in microspike formation and JNK activation through Cdc42 activation.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Dynamic reorganization of the actin cytoskeleton is implicated in many cell functions, including cell shape change, adhesion, and motility (for reviews, see Refs. 1-3). Evidence is accumulating that the Rho family small GTP-binding proteins (G proteins)1 are important regulators of these actin-dependent cell functions (for reviews, see Refs. 4-6). The Rho family consists of three major subfamilies: the Cdc42, Rac, and Rho subfamilies (Cdc42, Rac, and Rho, respectively). In fibroblasts, Cdc42 induces filopodium formation; Rac induces lamellipodium and membrane ruffle formation; and Rho regulates assembly of stress fibers and focal adhesions. In addition to these functions, the Rho family members are involved in the regulation of gene expression, cell growth, cell-cell adhesion, and cell motility (4-6).

The Rho family members cycle between the GDP-bound inactive and GTP-bound active forms (4-6). The conversion from the GDP-bound form to the GTP-bound form is stimulated by a GDP/GTP exchange factor (GEF). Many GEFs for the Rho family members have thus far been identified and shown to share two conserved domains: a Dbl homology domain (DHD) of about 250 amino acids (aa) and a pleckstrin homology domain (PHD) of about 100 aa adjacent to DHD. We have recently isolated a novel actin filament (F-actin)-binding protein, named frabin (7). Frabin has one F-actin-binding domain (ABD), one DHD, first PHD adjacent to DHD, one cysteine rich-domain (CRD), and second PHD from the N terminus to the C terminus in this order. This domain structure of frabin is similar to that of a GEF specific for Cdc42, FGD1, determined by positional cloning to be the genetic locus responsible for faciogenital dysplasia or Aarskog-Scott syndrome (8, 9), except that FGD1 lacks ABD but has a proline-rich domain. Overexpression of frabin in Swiss 3T3 cells and COS7 cells induces microspike formation and c-Jun N-terminal kinase (JNK) activation, respectively, as described for Cdc42 and FGD1 (9). However, we had not examined whether frabin shows GEF activity on Cdc42. In this study, we first examined this activity of frabin and then the role of each domain of frabin in microspike formation and JNK activation.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials and Chemicals-- Lipid-modified RhoA, Rac1, and Cdc42Hs were purified from the membrane fraction of Spodoptera frugiperda cells transfected with baculovirus carrying the respective cDNAs (10). Glutathione S-transferase (GST)-Dbl and GST-Rho GDP dissociation inhibitor (GDI) were prepared as described (10). The GST carrier of GST-Rho GDI was cleaved off from Rho GDI by digestion with thrombin. Primary cultured rat hippocampal neurons were prepared as described previously (11). A rabbit antiserum against frabin was raised against GST-frabin-h (aa 1-208) described below. This antiserum was affinity-purified with GST-frabin-h covalently coupled to N-hydroxysuccinimide-activated Sepharose (Amersham Pharmacia Biotech, Ltd.) and used as an anti-frabin antibody. A monoclonal anti-Myc antibody was from American Type Culture Collection (Manassas, VA). An anti-hemagglutinin (HA) antibody was prepared as described previously (12). pSRalpha -HA-JNKalpha and GST-c-Jun (13) were kindly supplied by Dr. E. Nishida (Kyoto University, Kyoto, Japan). pEF-BOS-Myc-V12Cdc42Hs was prepared as described previously (14). Phosphatidylinositol 4,5-diphosphate (PIP2) was purchased from Sigma.

Construction of Expression Vectors-- Eukaryotic and prokaryotic expression vectors of frabin were constructed in pCMV-Myc (11), pCMV-green fluorescent protein (GFP), and pGEX-KG (15) using standard molecular biology methods (16). Various pCMV-Myc constructs of frabin shown in Fig. 2A contained the following aa residues: pCMV-Myc-frabin-a, aa 1-766 (full length); pCMV-Myc-frabin-b, aa 1-150; pCMV-Myc-frabin-c, aa 151-766; pCMV-Myc-frabin-d, aa 169-539; and pCMV-Myc-frabin-e, aa 1-539. GST fusion constructs of frabin contained the following aa residues: GST-frabin-h, aa 1-208; and GST-frabin DH/PH, aa 169-539. pCMV-GFP was constructed by subcloning the insert encoding the GFP of pEGFP-N1 (CLONTECH) into pCMV5. pCMV-GFP-Frabin contained full-length frabin to express the fusion protein with the C-terminal GFP. The pCMV-Myc and pCMV-GFP constructs were transfected into COS7 cells using the DEAE-dextran method (17). The GST fusion proteins were purified by use of glutathione-Sepharose beads (Amersham Pharmacia Biotech Ltd.).

GEF Assay-- GEF activity of GST-frabin DH/PH and GST-Dbl was assayed by measuring the radioactivity of [3H]GDP bound to each lipid-modified small G protein (20 nM each) after incubation at 30 °C for 10 min in the presence or absence of an indicated amount of Rho GDI as described previously (10).

Assay for JNK Activity-- JNK activity was assayed as described previously (7, 13). Briefly, pSRalpha -HA-JNKalpha was transfected with various pCMV-Myc constructs of frabin or pEF-BOS-Myc-V12Cdc42Hs in COS7 cells using the DEAE-dextran method (17). After incubation for 16 h in serum-starved Dulbecco's modified Eagle's medium, the cell lysates were subjected to immunoprecipitation with the anti-HA antibody. Each immunoprecipitate was then washed and used to assay the phosphorylation of GST-c-Jun after incubation in the presence of [32P]ATP. The phosphorylation was detected by autoradiography and quantified using an image analyzer (Fujix BAS-2000II).

Other Procedures-- Immunofluorescence microscopy of cultured COS7 cells and hippocampal neurons were done as described (7, 11). Protein concentrations were determined with bovine serum albumin as a reference protein (18). SDS-polyacrylamide gel electrophoresis was done as described previously (19).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

GEF Activity of Frabin on Cdc42 and Its Responsible Domain-- FGD1 has been described to show GEF activity on Cdc42Hs, but not on Rac1 or RhoA (9). The domains responsible for this activity of FGD1 are DHD and first PHD (9). We first examined whether a GST fusion protein of frabin containing only these domains (GST-frabin DH/PH) shows GEF activity on Cdc42Hs. GST-frabin DH/PH showed GEF activity on Cdc42Hs in a dose-dependent manner (Fig. 1A). GST-Dbl also showed this activity as described (10), but the efficiency of GST-frabin DH/PH on Cdc42Hs activation was about 1.6% that of GST-Dbl (data not shown). GST-frabin DH/PH was inactive on RhoA and Rac1 under the conditions where GST-Dbl was active on all the three Rho family members (Fig. 1B). This result is consistent with the properties of FGD1 described previously (9). It has been shown that PHD binds acidic phospholipids, such as PIP2 (20). We examined the effect of PIP2 on GEF activity of frabin on Cdc42Hs. However, addition of various doses of PIP2 (0-20 µM) did not affect the activity of GST-frabin DH/PH (data not shown). It is not known at present why GEF activity of frabin is very low, but an unidentified factor(s) may enhance the activity.


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 1.   GEF activity of frabin. A, dose-dependent activity on Cdc42Hs. The dissociation of [3H]GDP from lipid-modified Cdc42Hs was assayed by incubation for 10 min with various doses of GST alone or GST-frabin DH/PH. , GST-frabin DH/PH; open circle , GST alone. B, GEF activity specific for Cdc42Hs. The dissociation of [3H]GDP from each lipid-modified small G protein was assayed by incubation for 10 min with 300 nM GST-frabin DH/PH, 5 nM GST-Dbl, or 300 nM GST alone. Hatched box, GST-frabin DH/PH; closed box, GST-Dbl; and open box, GST alone. C, inhibition of GEF activity by Rho GDI. The dissociation of [3H]GDP from lipid-modified Cdc42Hs was assayed by incubation for 10 min with 300 nM GST-frabin DH/PH or 5 nM GST-Dbl in the presence of various doses of Rho GDI. , GST-frabin DH/PH; black-triangle, GST-Dbl.

Rho GDI is a general regulator of all the Rho family members (4). We have previously shown that Rho GDI inhibits GEF activity of GST-Dbl on RhoA, Rac1, and Cdc42Hs (10). Similarly, Rho GDI inhibited GEF activity of GST-frabin DH/PH on Cdc42Hs in a dose-dependent manner (Fig. 1C).

Domains of Frabin for Microspike Formation-- We then determined the domains of frabin responsible for microspike formation in COS7 cells. We constructed the Myc-tagged, full-length and various fragments of frabin which contained various combinations of each domain (Fig. 2A). Each Myc-tagged protein was transiently expressed in COS7 cells and cell shape was analyzed by F-actin staining using fluorescent phalloidin. Consistent with our previous observation in Swiss 3T3 cells (7), full-length frabin (Myc-frabin-a) induced the formation of F-actin-containing microspikes at the periphery of cultured COS7 cells (Fig. 2, B and C). The microspikes were apparently similar to those induced by a dominant active mutant of Cdc42Hs (V12Cdc42Hs). To determine whether the frabin-induced microspikes were filopodia or retraction fibers, GFP-tagged, full-length frabin was transiently expressed in COS7 cells. Time-lapse phase-contrast microscopy of the expressing cells revealed that most microspikes were filopodia, but some of them were retraction fibers, consistent with an earlier observation with Cdc42Hs-induced microspikes (21) (data not shown). The fragment lacking ABD (Myc-frabin-c) induced the accumulation of F-actin at the cell periphery, but it did not induce microspike formation. Neither the fragment containing ABD alone (Myc-frabin-b) nor the fragment containing DHD and first PHD (Myc-frabin-d) induced microspike formation. The fragment containing ABD, DHD, and first PHD (Myc-frabin-e) induced microspike formation. Consistent with our previous observation (7), full-length frabin (Myc-frabin-a) and the fragments having ABD (Myc-frabin-b and -e) were colocalized with F-actin whereas the fragments lacking ABD (Myc-frabin-c and -d) showed diffuse distribution throughout the cytoplasm. These results indicate that ABD in addition to DHD and first PHD is necessary for microspike formation.


View larger version (50K):
[in this window]
[in a new window]
 
Fig. 2.   Domains of frabin responsible for microspike formation. A, structure of the full-length and various fragment of frabin. B, immunofluorescence microscopy. COS7 cells were transfected with pEF-BOS-Myc-V12Cdc42Hs or various pCMV-Myc constructs of frabin. The cells were doubly stained with the anti-Myc antibody and rhodamine-phalloidin. Bars, 20 µm. C, statistical analysis of microspike formation. The activity of microspike formation was represented by the percentage of cells with microspikes in cells positive for the Myc staining. The cells with microspikes were defined as cells with F-actin-containing thin protrusions (number of more than 10) at the cell periphery. Data shown represent means ± S.D. of three independent experiments. About 200 cells positive for the Myc staining were analyzed in each experiment.

Domains of Frabin for JNK Activation-- We have shown previously that full-length frabin induces JNK activation to an extent about 40% that induced by V12Cdc42Hs (7). We next analyzed the domains responsible for this activity. We coexpressed a fragment of frabin containing various combinations of each domain with HA-tagged JNK in COS7 cells. The expressed JNK was immunoprecipitated and its kinase activity toward GST-c-Jun was assayed. The fragment of frabin lacking ABD (Myc-frabin-c) induced JNK activation to the extent similar to that induced by full-length frabin (Myc-frabin-a) (Fig. 3, A and B). Neither the fragment containing ABD alone (Myc-frabin-b), the fragment containing DHD and first PHD (Myc-frabin-d), nor the fragment containing ABD, DHD, and first PHD (Myc-frabin-e) was active in this activity. These results indicate that DHD and first PHD are necessary not only for microspike formation but also for JNK activation, but that CRD and second PHD are additionally necessary for JNK activation.


View larger version (38K):
[in this window]
[in a new window]
 
Fig. 3.   Domains of frabin for JNK activation. A, phosphorylation of c-Jun. COS7 cells were transfected with pSRalpha -HA-JNKalpha along with pEF-BOS-Myc-V12Cdc42Hs or various pCMV-Myc constructs of frabin. pCMV-Myc vector was used as a control. HA-tagged JNK was then immunoprecipitated with the anti-HA antibody. A comparable amount of each immunoprecipitate was subjected to the assay for JNK activity using GST-c-Jun as a substrate. The phosphorylation of GST-c-Jun was detected by autoradiography. B, statistical analysis of JNK activation. The phosphorylation of GST-c-Jun was expressed as fold activation relative to the level of the phosphorylation with the pCMV-Myc vector control. Data shown represent means ± S.D. of three independent experiments.

Subcellular Localization and Tissue Distribution of Frabin-- We analyzed the localization of frabin in growth cones of cultured rat hippocampal neurons in which filopodia are markedly formed. Immunofluorescence microscopy showed that frabin was highly concentrated at filopodia and poorly detected at lamellipodia (Fig. 4A). We then examined tissue distribution of frabin in various rat adult tissues. Northern and Western blot analyses showed that frabin was expressed in all the tissues examined (Fig. 4, B and C). Lung and kidney showed strong signals on Northern blot analysis whereas brain and liver showed strong signals on Western blot analysis. The reason for this discrepancy is not known, but it may be due to the difference of the stability of frabin protein in various tissues. Two bands were detected on Western blot analysis. The exact relationship between these two bands remains to be clarified, but they may be splicing variants or posttranslationally modified forms, such as the phosphorylated form.


View larger version (49K):
[in this window]
[in a new window]
 
Fig. 4.   Subcellular localization and tissue distribution of frabin. A, localization in primary cultured rat hippocampal neurons. The hippocampal neurons (2 days in culture) were stained with the anti-frabin antibody. Arrow, growth cone; arrowhead, cell body. Inset a, staining of the inset b with rhodamine-phalloidin. Bar, 20 µm. B, Northern blot analysis. A RNA blot membrane (CLONTECH) was hybridized with 32P-labeled, 1.2-kilobase pair BamHI-XbaI fragment of the frabin cDNA according to the manufacturer's protocol. C, Western blot analysis. The homogenates of various rat tissues (20 µg of protein each) were subjected to SDS-polyacrylamide gel electrophoresis (10% polyacrylamide gel), followed by Western blot analysis with the anti-frabin antibody. Lanes 1, heart; lanes 2, brain; lanes 3, spleen; lanes 4, lung; lanes 5, liver; lanes 6, skeletal muscle; lanes 7, kidney; and lanes 8, testis.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

We have shown here that frabin shows GEF activity specific for Cdc42 as described for FGD1 (9). Like other GEFs for the Rho family members, frabin as well as FGD1 has both DHD and its adjacent PHD. The aa sequences of these domains of many GEFs for the Rho family members thus far identified are highly homologous. The aa sequences of DHD and its adjacent PHD of frabin show 26% and 23% identity to those of Dbl, respectively. However, those between frabin and FGD1 are more highly homologous than those among other GEFs: the aa sequences of DHD and its adjacent PHD of frabin show 71% and 57% identity to those of FGD1, respectively. Of the many GEFs for the Rho family members, only frabin and FGD1 are specific for Cdc42. It is likely that some specific region in these domains of frabin and FGD1 determines the specificity for Cdc42, but it remains unknown how each GEF determines their substrate specificity.

We have then analyzed here the role of ABD of frabin in microspike formation and JNK activation and shown that ABD is additionally necessary for microspike formation but not for JNK activation. In our previous (7) and present report, we have furthermore shown that full-length frabin (Myc-frabin-a) is associated with the actin cytoskeleton in intact cells and that the fragment of frabin lacking ABD (Myc-frabin-c) is diffusely distributed throughout the cytoplasm. Myc-frabin-c contains DHD and first PHD which are capable of activating Cdc42 in a cell-free system. This fragment of frabin is indeed active in intact cells, because it induces JNK activation. However, Myc-frabin-c is unable to induce microspike formation. It is likely that Cdc42 activation in the vicinity of the actin cytoskeleton is essential for reorganization of the actin cytoskeleton followed by microspike formation. It has been shown that a fragment of FGD1 containing only DHD and first PHD induces microspike formation through Cdc42 activation when microinjected into Swiss 3T3 cells (9, 22). It is not known why there is the difference in the ability of microspike formation between the similar fragments of FGD1 and frabin, but this difference may be due to experimental conditions: In the FGD1 experiments, Swiss 3T3 cells were used and the protein or cDNA samples were microinjected, whereas in our experiments, COS7 cells were used and the cDNA samples were transfected. However, it could be concluded, at least from these two experiments, that ABD is necessary for more efficient microspike formation.

In contrast, the association of frabin with the actin cytoskeleton is not essential for JNK activation. Of course, in intact cells, full-length frabin is associated with the actin cytoskeleton and activates Cdc42 around there, which then induces both microspike formation and JNK activation. It may be noted that the fragment of frabin lacking ABD (Myc-frabin-c) is active but the fragment of frabin containing only DHD and first PHD (Myc-frabin-d) is inactive for JNK activation. It is not known whether this fragment is capable of activating Cdc42 in intact cells, but these results suggest that ABD, CRD, and second PHD intramolecularly or intermolecularly affect the conformation of DHD and first PHD of frabin which determines GEF activity.

We have shown here that frabin is expressed in all the tissues thus far examined, but the protein is most abundant in brain and liver. The tissue distribution of frabin on Northern blot analysis is different from that of FGD1 which is expressed in heart, brain, lung, and skeletal muscle (8). We have moreover shown that frabin is localized at filopodia at least in growth cones of cultured neurons. It is not known how frabin is highly concentrated at filopodia, but this localization is consistent with its ability to induce microspike formation through Cdc42 activation. Frabin which is associated with the cortical actin cytoskeleton activates Cdc42, which then reorganizes the actin cytoskeleton to induce filopodium formation. Repetition of this process may lengthen the microspike. In other words, the frabin-Cdc42 system reorganizes the pre-existing actin cytoskeleton to a new structure. Further study is necessary to clarify how frabin is localized at filopodia and how it is activated there for our understanding of the mechanisms of microspike formation.

    ACKNOWLEDGEMENT

We thank Dr. E. Nishida (Kyoto University, Kyoto, Japan) for providing us with the GST-c-Jun and pSRalpha -HA-JNKalpha .

    FOOTNOTES

* The work performed at Osaka University Medical School was supported by grants-in-aid for Scientific Research and for Cancer Research from the Ministry of Education, Science, Sports, and Culture, Japan (1998) and by grants from the Human Frontier Science Program (1998).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ The first and second authors contributed equally to the experimental work.

parallel Present address: Eisai Company, Ltd., Tsukuba Research Laboratories, Dept. of Drug Discovery, 5-1-3 Tokodai, Tsukuba, Ibaraki 300-2635, Japan.

Dagger Dagger To whom correspondence should be addressed: Dept. of Molecular Biology and Biochemistry, Osaka University Medical School, Suita 565-0871, Osaka, Japan. Tel.: 81-6-6879-3410; Fax: 81-6-6879-3419; E-mail: ytakai@molbio.med.osaka-u.ac.jp.

    ABBREVIATIONS

The abbreviations used are: G protein, GTP-binding protein; GEF, GDP/GTP exchange factor; DHD, Dbl homology domain; aa, amino acid; PHD, pleckstrin homology domain; F-actin, actin filament; ABD, F-actin-binding domain; CRD, cysteine-rich domain; JNK, c-Jun N-terminal kinase; GST, glutathione S-transferase; GDI, GDP dissociation inhibitor; HA, hemagglutinin; PIP2, phosphatidylinositol 4,5-diphosphate; GFP, green fluorescent protein.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Pollard, T. D., and Cooper, J. A. (1986) Annu. Rev. Biochem. 55, 987-1035[CrossRef][Medline] [Order article via Infotrieve]
2. Gumbiner, B. M. (1996) Cell 84, 345-357[CrossRef][Medline] [Order article via Infotrieve]
3. Lauffenburger, D. A., and Horwitz, A. F. (1996) Cell 84, 359-369[CrossRef][Medline] [Order article via Infotrieve]
4. Takai, Y., Sasaki, T., Tanaka, K., and Nakanishi, H. (1995) Trends Biochem. Sci. 20, 227-231[CrossRef][Medline] [Order article via Infotrieve]
5. Hall, A. (1998) Science 279, 509-514[Abstract/Free Full Text]
6. Symons, M. (1996) Trends Biochem. Sci. 21, 178-181[CrossRef][Medline] [Order article via Infotrieve]
7. Obaishi, H., Nakanishi, H., Mandai, K., Satoh, K., Satoh, A., Takahashi, K., Miyahara, M., Nishioka, H., Takaishi, K., and Takai, Y. (1998) J. Biol. Chem. 273, 18697-18700[Abstract/Free Full Text]
8. Pasteris, N. G., Cadle, A., Logie, L. J., Porteous, M. E. M., Schwartz, C. E., Stevenson, R. E., Glover, T. W., Wilroy, R. S., and Gorski, J. L. (1994) Cell 79, 669-678[CrossRef][Medline] [Order article via Infotrieve]
9. Zheng, Y., Fischer, D. J., Santos, M. F., Tigyi, G., Pasteris, N. G., Gorski, J. L., and Xu, Y. (1996) J. Biol. Chem. 271, 33169-33172[Abstract/Free Full Text]
10. Yaku, H., Sasaki, T., and Takai, Y. (1994) Biochem. Biophys. Res. Commun. 198, 811-817[CrossRef][Medline] [Order article via Infotrieve]
11. Nakanishi, H., Obaishi, H., Satoh, A., Wada, M., Mandai, K., Satoh, K., Nishioka, H., Matsuura, Y., Mizoguchi, A., and Takai, Y. (1997) J. Cell Biol. 139, 951-961[Abstract/Free Full Text]
12. Yamochi, W., Tanaka, K., Nonaka, H., Maeda, A., Musha, T., and Takai, Y. (1994) J. Cell Biol. 125, 1077-1093[Abstract/Free Full Text]
13. Moriguchi, T., Kuroyanagi, N., Yamaguchi, K., Gotoh, Y., Irie, K., Kano, T., Shirakabe, K., Muro, Y., Shibuya, H., Matsumoto, K., Nishida, E., and Hagiwara, M. (1996) J. Biol. Chem. 271, 13675-13679[Abstract/Free Full Text]
14. Komuro, R., Sasaki, T., Takaishi, K., Orita, S., and Takai, Y. (1996) Genes Cells 1, 943-951 [Abstract]
15. Guan, K. L., and Dixon, J. E. (1991) Anal. Biochem. 192, 262-267[CrossRef][Medline] [Order article via Infotrieve]
16. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , 2nd Ed. , Cold Spring Harbor Press, Cold Spring Harbor, NY
17. Hata, Y., and Südhof, T. C. (1995) J. Biol. Chem. 270, 13022-13028[Abstract/Free Full Text]
18. Bradford, M. M. (1976) Anal. Biochem. 72, 248-254[CrossRef][Medline] [Order article via Infotrieve]
19. Laemmli, U. K. (1970) Nature 227, 680-685[CrossRef][Medline] [Order article via Infotrieve]
20. Harlan, J. E., Hajduk, P. J., Yoon, H., and Fesik, S. W. (1994) Nature 371, 168-170[CrossRef][Medline] [Order article via Infotrieve]
21. Kozma, R., Ahmed, S., Best, A., and Lim, L. (1995) Mol. Cell. Biol. 15, 1942-1952[Abstract]
22. Nagata, K., Driessens, M., Lamarche, N., Gorski, J. L., and Hall, A. (1998) J. Biol. Chem. 273, 15453-15457[Abstract/Free Full Text]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.



This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
F. L. Robinson, I. R. Niesman, K. K. Beiswenger, and J. E. Dixon
Loss of the inactive myotubularin-related phosphatase Mtmr13 leads to a Charcot-Marie-Tooth 4B2-like peripheral neuropathy in mice
PNAS, March 25, 2008; 105(12): 4916 - 4921.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
S. Hisata, T. Sakisaka, T. Baba, T. Yamada, K. Aoki, M. Matsuda, and Y. Takai
Rap1-PDZ-GEF1 interacts with a neurotrophin receptor at late endosomes, leading to sustained activation of Rap1 and ERK and neurite outgrowth
J. Cell Biol., August 27, 2007; 178(5): 843 - 860.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Yamada, T. Sakisaka, S. Hisata, T. Baba, and Y. Takai
RA-RhoGAP, Rap-activated Rho GTPase-activating Protein Implicated in Neurite Outgrowth through Rho
J. Biol. Chem., September 23, 2005; 280(38): 33026 - 33034.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Taira, M. Umikawa, K. Takei, B.-E. Myagmar, M. Shinzato, N. Machida, H. Uezato, S. Nonaka, and K.-i. Kariya
The Traf2- and Nck-interacting Kinase as a Putative Effector of Rap2 to Regulate Actin Cytoskeleton
J. Biol. Chem., November 19, 2004; 279(47): 49488 - 49496.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
C. Huang, K. Jacobson, and M. D. Schaller
MAP kinases and cell migration
J. Cell Sci., September 15, 2004; 117(20): 4619 - 4628.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
T. Fukuhara, K. Shimizu, T. Kawakatsu, T. Fukuyama, Y. Minami, T. Honda, T. Hoshino, T. Yamada, H. Ogita, M. Okada, et al.
Activation of Cdc42 by trans interactions of the cell adhesion molecules nectins through c-Src and Cdc42-GEF FRG
J. Cell Biol., August 2, 2004; 166(3): 393 - 405.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Machida, M. Umikawa, K. Takei, N. Sakima, B.-E. Myagmar, K. Taira, H. Uezato, Y. Ogawa, and K.-i. Kariya
Mitogen-activated Protein Kinase Kinase Kinase Kinase 4 as a Putative Effector of Rap2 to Activate the c-Jun N-terminal Kinase
J. Biol. Chem., April 16, 2004; 279(16): 15711 - 15714.
[Abstract] [Full Text] [PDF]


Home page
J Exp BotHome page
J. Samaj, F. Baluska, and H. Hirt
From signal to cell polarity: mitogen-activated protein kinases as sensors and effectors of cytoskeleton dynamicity
J. Exp. Bot., January 2, 2004; 55(395): 189 - 198.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. Souchet, E. Portales-Casamar, D. Mazurais, S. Schmidt, I. Leger, J.-L. Javre, P. Robert, I. Berrebi-Bertrand, A. Bril, B. Gout, et al.
Human p63RhoGEF, a novel RhoA-specific guanine nucleotide exchange factor, is localized in cardiac sarcomere
J. Cell Sci., January 2, 2002; 115(3): 629 - 640.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
L. Estrada, E. Caron, and J. L. Gorski
Fgd1, the Cdc42 guanine nucleotide exchange factor responsible for faciogenital dysplasia, is localized to the subcortical actin cytoskeleton and Golgi membrane
Hum. Mol. Genet., March 1, 2001; 10(5): 485 - 495.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
Y. Takai, T. Sasaki, and T. Matozaki
Small GTP-Binding Proteins
Physiol Rev, January 1, 2001; 81(1): 153 - 208.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Umikawa, M.
Right arrow Articles by Takai, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Umikawa, M.
Right arrow Articles by Takai, Y.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.